Vectura Group plc - Interim Results For The Six Months Ended 30 September 2009
11/30/2009 1:45:28 PM
More...
|
Vectura Group plc: Update on NVA237 and QVA149 for Chronic Obstructive Pulmonary Disease
10/22/2009 2:11:15 PM
More...
|
Vectura Group plc: Interim Management Statement
8/18/2009 12:40:44 PM
More...
|
Vectura Group plc Receives $6 Million Milestone Payment for VR315
8/13/2009 8:22:07 AM
More...
|
Sosei Group Corporation and Vectura Group plc Announce Start of Phase III Clinical Study With NVA237
6/29/2009 8:29:36 AM
More...
|
Vectura Group plc Receives €2.5m Milestone Payment For VR315
4/21/2009 1:19:38 PM
More...
|
Vectura Group plc: Interim Management Statement
1/28/2009 8:38:51 AM
More...
|
Vectura Group plc - Interim Results For The Six Months Ended 30 September 2008
11/24/2008 12:35:24 PM
More...
|
Vectura Group plc Receives €7.5 Million Milestone from Boehringer Ingelheim Corporation
10/31/2008 7:16:58 AM
More...
|
Vectura Group plc Confirms Sandoz Pharma A.G. as Partner on VR315 and VR632
9/9/2008 2:29:13 PM
More...
|
|